| 1. | Which of the following statements about long COVID is true? |
| A. | Asymptomatic acute COVID infection can lead to long COVID. |
| B. | The disease course is typically relapsing and remitting. |
| C. | Studies showed that the male sex is a risk factor. |
| D. | There is no evidence showing that COVID vaccination would lower the risk of developing Long COVID. |
| E. | It is defined by the WHO as symptoms that last for at least 1 month after a probable or confirmed SARS-CoV-2 infection. |
| 2. | Which of the following about post-exertional symptom exacerbation is true? |
| A. | It typically starts immediately after exertion. |
| B. | It usually follows strenuous exertion. |
| C. | Increased exercise can be harmful in these patients. |
| D. | It usually follows a constant and deteriorating course. |
| E. | It is commonly associated with orthostatic hemodynamic changes. |
| 3. | Which of the following about management of Long COVID is FALSE? |
| A. | Probiotics is a potential treatment option. |
| B. | Rehabilitative approach is the mainstay of treatment. |
| C. | Exercise in a non-upright position is suitable for patients suffering from orthostatic intolerance. |
| D. | Pacing is important in managing fatigue in Long COVID patients. |
| E. | Graded exercise is recommended for all Long COVID patients. |
| 4. | In the study titled ‘How well can family physicians manage osteoporosis? A retrospective case series in a local public clinic in Hong Kong’, what service is not provided in the multidisciplinary osteoporosis clinic? |
| A. | A health talk on osteoporosis by a nurse. |
| B. | An individual counselling session by a nurse with individual FRAX score calculation and advice offered accordingly. |
| C. | A consultation session with doctors equipped with updated knowledge regarding osteoporosis management. |
| D. | Alendronate is prescribed to all patient for free. |
| E. | Allied health services such as dietitian counselling, physiotherapy and occupational therapy is included in the management plan as needed. |
| 5. | What is the approximate prevalence of osteoporosis in postmenopausal women worldwide? |
| A. | 10% |
| B. | 20% |
| C. | 30% |
| D. | 50% |
| E. | 70% |
| 6. | According to the International Society for Clinical Densitometry (ISCD) and American Association of clinical endocrinologists (AACE), how often should DEXA scan be repeated after the initiation of pharmacological treatment for osteoporotic patients? |
| A. | Every 6 months. |
| B. | Every 1-2 years. |
| C. | Every 2-3 years. |
| D. | Every 3 years. |
| E. | Every 5 years. |